On the basis of our identification of an association between markers in the blood and the densities of immune cells in the tumor microenvironment, we proposed that the CEA level, number of monocytes, LMR, and ApoA1 may be used to ascertain the immunological status in the tumor microenvironment. The gene discussed is CEACAM5; the disease is neoplasm.